Wahl ML[au] - Search Results

Year	Number of Results
1995	1
1996	1
1997	3
1998	2
2000	2
2001	1
2002	6
2003	3
2004	3
2005	4
2006	2
2007	1
2008	1
2009	1
2010	1
2011	1
2021	0

1

Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice.

Sonveaux P, Végran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, De Saedeleer CJ, Kennedy KM, Diepart C, Jordan BF, Kelley MJ, Gallez B, Wahl ML, Feron O, Dewhirst MW. Sonveaux P, et al. Among authors: wahl ml. J Clin Invest. 2008 Dec;118(12):3930-42. doi: 10.1172/JCI36843. Epub 2008 Nov 20. J Clin Invest. 2008. PMID: 19033663 Free PMC article.

2

Proton dynamics in cancer.

Huber V, De Milito A, Harguindey S, Reshkin SJ, Wahl ML, Rauch C, Chiesi A, Pouysségur J, Gatenby RA, Rivoltini L, Fais S. Huber V, et al. Among authors: wahl ml. J Transl Med. 2010 Jun 15;8:57. doi: 10.1186/1479-5876-8-57. J Transl Med. 2010. PMID: 20550689 Free PMC article.

3

Proton transport inhibitors as potentially selective anticancer drugs.

Harguindey S, Arranz JL, Wahl ML, Orive G, Reshkin SJ. Harguindey S, et al. Among authors: wahl ml. Anticancer Res. 2009 Jun;29(6):2127-36. Anticancer Res. 2009. PMID: 19528473 Free article. Review.

4

Angiostatin and anti-angiogenic therapy in human disease.

Wahl ML, Moser TL, Pizzo SV. Wahl ML, et al. Recent Prog Horm Res. 2004;59:73-104. doi: 10.1210/rp.59.1.73. Recent Prog Horm Res. 2004. PMID: 14749498 Review.

5

Teaching new dogs old tricks: membrane biophysical properties in drug delivery and resistance.

Milosavljevic N, Blanchard A, Wahl ML, Harguindey S, Poet M, Counillon L, Rauch C. Milosavljevic N, et al. Among authors: wahl ml. Recent Pat Anticancer Drug Discov. 2011 Sep;6(3):334-46. doi: 10.2174/157489211796957829. Recent Pat Anticancer Drug Discov. 2011. PMID: 21756245 Free article. Review.

6

Angiostatin's molecular mechanism: aspects of specificity and regulation elucidated.

Wahl ML, Kenan DJ, Gonzalez-Gronow M, Pizzo SV. Wahl ML, et al. J Cell Biochem. 2005 Oct 1;96(2):242-61. doi: 10.1002/jcb.20480. J Cell Biochem. 2005. PMID: 16094651 Review.

7

Ectopic localization of mitochondrial ATP synthase: a target for anti-angiogenesis intervention?

Kenan DJ, Wahl ML. Kenan DJ, et al. Among authors: wahl ml. J Bioenerg Biomembr. 2005 Dec;37(6):461-5. doi: 10.1007/s10863-005-9492-x. J Bioenerg Biomembr. 2005. PMID: 16691484 Review.

8

The mechanism of action of angiostatin: can you teach an old dog new tricks?

Moser TL, Stack MS, Wahl ML, Pizzo SV. Moser TL, et al. Among authors: wahl ml. Thromb Haemost. 2002 Mar;87(3):394-401. Thromb Haemost. 2002. PMID: 11916069 Review.

9

Angiostatin-like activity of a monoclonal antibody to the catalytic subunit of F1F0 ATP synthase.

Chi SL, Wahl ML, Mowery YM, Shan S, Mukhopadhyay S, Hilderbrand SC, Kenan DJ, Lipes BD, Johnson CE, Marusich MF, Capaldi RA, Dewhirst MW, Pizzo SV. Chi SL, et al. Among authors: wahl ml. Cancer Res. 2007 May 15;67(10):4716-24. doi: 10.1158/0008-5472.CAN-06-1094. Cancer Res. 2007. PMID: 17510399 Free article.

10

The H+-linked monocarboxylate transporter (MCT1/SLC16A1): a potential therapeutic target for high-risk neuroblastoma.

Fang J, Quinones QJ, Holman TL, Morowitz MJ, Wang Q, Zhao H, Sivo F, Maris JM, Wahl ML. Fang J, et al. Among authors: wahl ml. Mol Pharmacol. 2006 Dec;70(6):2108-15. doi: 10.1124/mol.106.026245. Epub 2006 Sep 25. Mol Pharmacol. 2006. PMID: 17000864

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results